Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Ligand Pharmaceuticals Community
NasdaqGM:LGND Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Community Investing Ideas
Ligand Pharmaceuticals
Popular
Undervalued
Overvalued
Ligand Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Expanding Royalty Portfolio Will Strengthen Global Healthcare Reach
Key Takeaways Diverse royalty partnerships, new therapeutic categories, and global healthcare trends boost recurring revenue, earnings visibility, and long-term margin potential. Opportunistic asset-light acquisitions and strong industry positioning underpin margin expansion, pipeline growth, and sustained revenue momentum.
View narrative
US$162.25
FV
6.9% undervalued
intrinsic discount
18.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
LGND
LGND
Ligand Pharmaceuticals
Your Fair Value
US$
Current Price
US$151.08
236.0% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-76m
677m
2015
2018
2021
2024
2025
2027
2030
Revenue US$402.1m
Earnings US$58.9m
Advanced
Set Fair Value